|
WO2015131245A1
|
|
Sepsis treatment
|
|
WO2014040115A1
|
|
Cellular bioassay
|
|
WO2011057333A1
|
|
Transgenic plant male sterility
|
|
TW201118789A
|
|
Method and system for energy management
|
|
WO2006000015A1
|
|
Stimulus generation
|
|
WO2005079781A1
|
|
Therapeutic and/or prophylactic method
|
|
AU2002953237A0
|
|
5-Oxazolidinones and 6-oxazinanones
|
|
AU2002950136A0
|
|
N-methyl amino acids
|
|
AU2002950126A0
|
|
Process for the production of n-substituted amino acids
|
|
AU2002950127A0
|
|
5-Oxazolidinones and 6-oxazinanones
|
|
AUPS234402A0
|
|
Anti-tumour polycyclic carboxamides
|
|
AU9525101A
|
|
Anti-tumour compounds
|
|
AUPR427301A0
|
|
Method for detection of gastrointestinal nematode infections
|
|
AUPR064300A0
|
|
Anti-tumour compounds
|
|
AUPR059400A0
|
|
Formaldehyde-releasing prodrugs
|
|
AUPQ990800A0
|
|
A data transfer switch and a method of switching data
|
|
AU6253900A
|
|
Method for detection of mite infection
|
|
AUPQ207699A0
|
|
Method for detection of mite infection
|
|
AUPP696398A0
|
|
Regulation of plant life pollen formation
|
|
AUPP617798A0
|
|
Topoisomerase inhibitors
|
